img

Global C1 Esterase Inhibitor Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global C1 Esterase Inhibitor Market Insights, Forecast to 2034

C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood. 
Global C1 Esterase Inhibitor market is expected to reach to US$ 136 million in 2024, with a positive growth of %, compared with US$ 128.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, C1 Esterase Inhibitor industry is evaluated to reach US$ 194 million in 2029. The CAGR will be 6.1% during 2024 to 2029.
The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.
Report Covers
This report presents an overview of global C1 Esterase Inhibitor market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global C1 Esterase Inhibitor market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL Behring
Takeda
Pharming Intellectual
Segment by Type
Human
Recombinant

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ C1 Esterase Inhibitor plant distribution, commercial date of C1 Esterase Inhibitor, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, C1 Esterase Inhibitor introduction, etc. C1 Esterase Inhibitor Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of C1 Esterase Inhibitor
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 C1 Esterase Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Human
1.2.3 Recombinant
1.3 Market by Application
1.3.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global C1 Esterase Inhibitor Sales Estimates and Forecasts 2018-2029
2.2 Global C1 Esterase Inhibitor Revenue by Region
2.2.1 Global C1 Esterase Inhibitor Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global C1 Esterase Inhibitor Revenue by Region (2018-2024)
2.2.3 Global C1 Esterase Inhibitor Revenue by Region (2024-2029)
2.2.4 Global C1 Esterase Inhibitor Revenue Market Share by Region (2018-2029)
2.3 Global C1 Esterase Inhibitor Sales Estimates and Forecasts 2018-2029
2.4 Global C1 Esterase Inhibitor Sales by Region
2.4.1 Global C1 Esterase Inhibitor Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global C1 Esterase Inhibitor Sales by Region (2018-2024)
2.4.3 Global C1 Esterase Inhibitor Sales by Region (2024-2029)
2.4.4 Global C1 Esterase Inhibitor Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global C1 Esterase Inhibitor Sales by Manufacturers
3.1.1 Global C1 Esterase Inhibitor Sales by Manufacturers (2018-2024)
3.1.2 Global C1 Esterase Inhibitor Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of C1 Esterase Inhibitor in 2022
3.2 Global C1 Esterase Inhibitor Revenue by Manufacturers
3.2.1 Global C1 Esterase Inhibitor Revenue by Manufacturers (2018-2024)
3.2.2 Global C1 Esterase Inhibitor Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by C1 Esterase Inhibitor Revenue in 2022
3.3 Global Key Players of C1 Esterase Inhibitor, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global C1 Esterase Inhibitor Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of C1 Esterase Inhibitor, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of C1 Esterase Inhibitor, Product Offered and Application
3.8 Global Key Manufacturers of C1 Esterase Inhibitor, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global C1 Esterase Inhibitor Sales by Type
4.1.1 Global C1 Esterase Inhibitor Historical Sales by Type (2018-2024)
4.1.2 Global C1 Esterase Inhibitor Forecasted Sales by Type (2024-2029)
4.1.3 Global C1 Esterase Inhibitor Sales Market Share by Type (2018-2029)
4.2 Global C1 Esterase Inhibitor Revenue by Type
4.2.1 Global C1 Esterase Inhibitor Historical Revenue by Type (2018-2024)
4.2.2 Global C1 Esterase Inhibitor Forecasted Revenue by Type (2024-2029)
4.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Type (2018-2029)
4.3 Global C1 Esterase Inhibitor Price by Type
4.3.1 Global C1 Esterase Inhibitor Price by Type (2018-2024)
4.3.2 Global C1 Esterase Inhibitor Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global C1 Esterase Inhibitor Sales by Application
5.1.1 Global C1 Esterase Inhibitor Historical Sales by Application (2018-2024)
5.1.2 Global C1 Esterase Inhibitor Forecasted Sales by Application (2024-2029)
5.1.3 Global C1 Esterase Inhibitor Sales Market Share by Application (2018-2029)
5.2 Global C1 Esterase Inhibitor Revenue by Application
5.2.1 Global C1 Esterase Inhibitor Historical Revenue by Application (2018-2024)
5.2.2 Global C1 Esterase Inhibitor Forecasted Revenue by Application (2024-2029)
5.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Application (2018-2029)
5.3 Global C1 Esterase Inhibitor Price by Application
5.3.1 Global C1 Esterase Inhibitor Price by Application (2018-2024)
5.3.2 Global C1 Esterase Inhibitor Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada C1 Esterase Inhibitor Market Size by Type
6.1.1 US & Canada C1 Esterase Inhibitor Sales by Type (2018-2029)
6.1.2 US & Canada C1 Esterase Inhibitor Revenue by Type (2018-2029)
6.2 US & Canada C1 Esterase Inhibitor Market Size by Application
6.2.1 US & Canada C1 Esterase Inhibitor Sales by Application (2018-2029)
6.2.2 US & Canada C1 Esterase Inhibitor Revenue by Application (2018-2029)
6.3 US & Canada C1 Esterase Inhibitor Market Size by Country
6.3.1 US & Canada C1 Esterase Inhibitor Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada C1 Esterase Inhibitor Sales by Country (2018-2029)
6.3.3 US & Canada C1 Esterase Inhibitor Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe C1 Esterase Inhibitor Market Size by Type
7.1.1 Europe C1 Esterase Inhibitor Sales by Type (2018-2029)
7.1.2 Europe C1 Esterase Inhibitor Revenue by Type (2018-2029)
7.2 Europe C1 Esterase Inhibitor Market Size by Application
7.2.1 Europe C1 Esterase Inhibitor Sales by Application (2018-2029)
7.2.2 Europe C1 Esterase Inhibitor Revenue by Application (2018-2029)
7.3 Europe C1 Esterase Inhibitor Market Size by Country
7.3.1 Europe C1 Esterase Inhibitor Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe C1 Esterase Inhibitor Sales by Country (2018-2029)
7.3.3 Europe C1 Esterase Inhibitor Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China C1 Esterase Inhibitor Market Size
8.1.1 China C1 Esterase Inhibitor Sales (2018-2029)
8.1.2 China C1 Esterase Inhibitor Revenue (2018-2029)
8.2 China C1 Esterase Inhibitor Market Size by Application
8.2.1 China C1 Esterase Inhibitor Sales by Application (2018-2029)
8.2.2 China C1 Esterase Inhibitor Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia C1 Esterase Inhibitor Market Size by Type
9.1.1 Asia C1 Esterase Inhibitor Sales by Type (2018-2029)
9.1.2 Asia C1 Esterase Inhibitor Revenue by Type (2018-2029)
9.2 Asia C1 Esterase Inhibitor Market Size by Application
9.2.1 Asia C1 Esterase Inhibitor Sales by Application (2018-2029)
9.2.2 Asia C1 Esterase Inhibitor Revenue by Application (2018-2029)
9.3 Asia C1 Esterase Inhibitor Sales by Region
9.3.1 Asia C1 Esterase Inhibitor Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia C1 Esterase Inhibitor Revenue by Region (2018-2029)
9.3.3 Asia C1 Esterase Inhibitor Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Market Size by Type
10.1.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Market Size by Application
10.2.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country
10.3.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring C1 Esterase Inhibitor Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CSL Behring C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Overview
11.2.3 Takeda C1 Esterase Inhibitor Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Takeda C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Takeda Recent Developments
11.3 Pharming Intellectual
11.3.1 Pharming Intellectual Company Information
11.3.2 Pharming Intellectual Overview
11.3.3 Pharming Intellectual C1 Esterase Inhibitor Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pharming Intellectual C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pharming Intellectual Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 C1 Esterase Inhibitor Industry Chain Analysis
12.2 C1 Esterase Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 C1 Esterase Inhibitor Production Mode & Process
12.4 C1 Esterase Inhibitor Sales and Marketing
12.4.1 C1 Esterase Inhibitor Sales Channels
12.4.2 C1 Esterase Inhibitor Distributors
12.5 C1 Esterase Inhibitor Customers
13 Market Dynamics
13.1 C1 Esterase Inhibitor Industry Trends
13.2 C1 Esterase Inhibitor Market Drivers
13.3 C1 Esterase Inhibitor Market Challenges
13.4 C1 Esterase Inhibitor Market Restraints
14 Key Findings in The Global C1 Esterase Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global C1 Esterase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Human
Table 3. Major Manufacturers of Recombinant
Table 4. Global C1 Esterase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global C1 Esterase Inhibitor Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global C1 Esterase Inhibitor Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global C1 Esterase Inhibitor Revenue Market Share by Region (2018-2024)
Table 9. Global C1 Esterase Inhibitor Revenue Market Share by Region (2024-2029)
Table 10. Global C1 Esterase Inhibitor Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global C1 Esterase Inhibitor Sales by Region (2018-2024) & (K Unit)
Table 12. Global C1 Esterase Inhibitor Sales by Region (2024-2029) & (K Unit)
Table 13. Global C1 Esterase Inhibitor Sales Market Share by Region (2018-2024)
Table 14. Global C1 Esterase Inhibitor Sales Market Share by Region (2024-2029)
Table 15. Global C1 Esterase Inhibitor Sales by Manufacturers (2018-2024) & (K Unit)
Table 16. Global C1 Esterase Inhibitor Sales Share by Manufacturers (2018-2024)
Table 17. Global C1 Esterase Inhibitor Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global C1 Esterase Inhibitor Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of C1 Esterase Inhibitor, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. C1 Esterase Inhibitor Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global C1 Esterase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global C1 Esterase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor as of 2022)
Table 23. Global Key Manufacturers of C1 Esterase Inhibitor, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of C1 Esterase Inhibitor, Product Offered and Application
Table 25. Global Key Manufacturers of C1 Esterase Inhibitor, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global C1 Esterase Inhibitor Sales by Type (2018-2024) & (K Unit)
Table 28. Global C1 Esterase Inhibitor Sales by Type (2024-2029) & (K Unit)
Table 29. Global C1 Esterase Inhibitor Sales Share by Type (2018-2024)
Table 30. Global C1 Esterase Inhibitor Sales Share by Type (2024-2029)
Table 31. Global C1 Esterase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global C1 Esterase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global C1 Esterase Inhibitor Revenue Share by Type (2018-2024)
Table 34. Global C1 Esterase Inhibitor Revenue Share by Type (2024-2029)
Table 35. C1 Esterase Inhibitor Price by Type (2018-2024) & (USD/Unit)
Table 36. Global C1 Esterase Inhibitor Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global C1 Esterase Inhibitor Sales by Application (2018-2024) & (K Unit)
Table 38. Global C1 Esterase Inhibitor Sales by Application (2024-2029) & (K Unit)
Table 39. Global C1 Esterase Inhibitor Sales Share by Application (2018-2024)
Table 40. Global C1 Esterase Inhibitor Sales Share by Application (2024-2029)
Table 41. Global C1 Esterase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global C1 Esterase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global C1 Esterase Inhibitor Revenue Share by Application (2018-2024)
Table 44. Global C1 Esterase Inhibitor Revenue Share by Application (2024-2029)
Table 45. C1 Esterase Inhibitor Price by Application (2018-2024) & (USD/Unit)
Table 46. Global C1 Esterase Inhibitor Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada C1 Esterase Inhibitor Sales by Type (2018-2024) & (K Unit)
Table 48. US & Canada C1 Esterase Inhibitor Sales by Type (2024-2029) & (K Unit)
Table 49. US & Canada C1 Esterase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada C1 Esterase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada C1 Esterase Inhibitor Sales by Application (2018-2024) & (K Unit)
Table 52. US & Canada C1 Esterase Inhibitor Sales by Application (2024-2029) & (K Unit)
Table 53. US & Canada C1 Esterase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada C1 Esterase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada C1 Esterase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada C1 Esterase Inhibitor Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada C1 Esterase Inhibitor Sales by Country (2018-2024) & (K Unit)
Table 59. US & Canada C1 Esterase Inhibitor Sales by Country (2024-2029) & (K Unit)
Table 60. Europe C1 Esterase Inhibitor Sales by Type (2018-2024) & (K Unit)
Table 61. Europe C1 Esterase Inhibitor Sales by Type (2024-2029) & (K Unit)
Table 62. Europe C1 Esterase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe C1 Esterase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe C1 Esterase Inhibitor Sales by Application (2018-2024) & (K Unit)
Table 65. Europe C1 Esterase Inhibitor Sales by Application (2024-2029) & (K Unit)
Table 66. Europe C1 Esterase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe C1 Esterase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe C1 Esterase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe C1 Esterase Inhibitor Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe C1 Esterase Inhibitor Sales by Country (2018-2024) & (K Unit)
Table 72. Europe C1 Esterase Inhibitor Sales by Country (2024-2029) & (K Unit)
Table 73. China C1 Esterase Inhibitor Sales by Type (2018-2024) & (K Unit)
Table 74. China C1 Esterase Inhibitor Sales by Type (2024-2029) & (K Unit)
Table 75. China C1 Esterase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 76. China C1 Esterase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 77. China C1 Esterase Inhibitor Sales by Application (2018-2024) & (K Unit)
Table 78. China C1 Esterase Inhibitor Sales by Application (2024-2029) & (K Unit)
Table 79. China C1 Esterase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 80. China C1 Esterase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia C1 Esterase Inhibitor Sales by Type (2018-2024) & (K Unit)
Table 82. Asia C1 Esterase Inhibitor Sales by Type (2024-2029) & (K Unit)
Table 83. Asia C1 Esterase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia C1 Esterase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia C1 Esterase Inhibitor Sales by Application (2018-2024) & (K Unit)
Table 86. Asia C1 Esterase Inhibitor Sales by Application (2024-2029) & (K Unit)
Table 87. Asia C1 Esterase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia C1 Esterase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia C1 Esterase Inhibitor Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia C1 Esterase Inhibitor Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia C1 Esterase Inhibitor Sales by Region (2018-2024) & (K Unit)
Table 93. Asia C1 Esterase Inhibitor Sales by Region (2024-2029) & (K Unit)
Table 94. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Type (2018-2024) & (K Unit)
Table 95. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Type (2024-2029) & (K Unit)
Table 96. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Application (2018-2024) & (K Unit)
Table 99. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Application (2024-2029) & (K Unit)
Table 100. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country (2018-2024) & (K Unit)
Table 106. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country (2024-2029) & (K Unit)
Table 107. CSL Behring Company Information
Table 108. CSL Behring Description and Major Businesses
Table 109. CSL Behring C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. CSL Behring C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Behring Recent Developments
Table 112. Takeda Company Information
Table 113. Takeda Description and Major Businesses
Table 114. Takeda C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Takeda C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Takeda Recent Developments
Table 117. Pharming Intellectual Company Information
Table 118. Pharming Intellectual Description and Major Businesses
Table 119. Pharming Intellectual C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Pharming Intellectual C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pharming Intellectual Recent Developments
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. C1 Esterase Inhibitor Distributors List
Table 125. C1 Esterase Inhibitor Customers List
Table 126. C1 Esterase Inhibitor Market Trends
Table 127. C1 Esterase Inhibitor Market Drivers
Table 128. C1 Esterase Inhibitor Market Challenges
Table 129. C1 Esterase Inhibitor Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. C1 Esterase Inhibitor Product Picture
Figure 2. Global C1 Esterase Inhibitor Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global C1 Esterase Inhibitor Market Share by Type in 2022 & 2029
Figure 4. Human Product Picture
Figure 5. Recombinant Product Picture
Figure 6. Global C1 Esterase Inhibitor Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global C1 Esterase Inhibitor Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. C1 Esterase Inhibitor Report Years Considered
Figure 11. Global C1 Esterase Inhibitor Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global C1 Esterase Inhibitor Revenue 2018-2029 (US$ Million)
Figure 13. Global C1 Esterase Inhibitor Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global C1 Esterase Inhibitor Revenue Market Share by Region (2018-2029)
Figure 15. Global C1 Esterase Inhibitor Sales 2018-2029 ((K Unit)
Figure 16. Global C1 Esterase Inhibitor Sales Market Share by Region (2018-2029)
Figure 17. US & Canada C1 Esterase Inhibitor Sales YoY (2018-2029) & (K Unit)
Figure 18. US & Canada C1 Esterase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe C1 Esterase Inhibitor Sales YoY (2018-2029) & (K Unit)
Figure 20. Europe C1 Esterase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China C1 Esterase Inhibitor Sales YoY (2018-2029) & (K Unit)
Figure 22. China C1 Esterase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) C1 Esterase Inhibitor Sales YoY (2018-2029) & (K Unit)
Figure 24. Asia (excluding China) C1 Esterase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales YoY (2018-2029) & (K Unit)
Figure 26. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The C1 Esterase Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of C1 Esterase Inhibitor in the World: Market Share by C1 Esterase Inhibitor Revenue in 2022
Figure 29. Global C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global C1 Esterase Inhibitor Sales Market Share by Type (2018-2029)
Figure 31. Global C1 Esterase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 32. Global C1 Esterase Inhibitor Sales Market Share by Application (2018-2029)
Figure 33. Global C1 Esterase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada C1 Esterase Inhibitor Sales Market Share by Type (2018-2029)
Figure 35. US & Canada C1 Esterase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada C1 Esterase Inhibitor Sales Market Share by Application (2018-2029)
Figure 37. US & Canada C1 Esterase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada C1 Esterase Inhibitor Revenue Share by Country (2018-2029)
Figure 39. US & Canada C1 Esterase Inhibitor Sales Share by Country (2018-2029)
Figure 40. U.S. C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 41. Canada C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 42. Mexico C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 43. Europe C1 Esterase Inhibitor Sales Market Share by Type (2018-2029)
Figure 44. Europe C1 Esterase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 45. Europe C1 Esterase Inhibitor Sales Market Share by Application (2018-2029)
Figure 46. Europe C1 Esterase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 47. Europe C1 Esterase Inhibitor Revenue Share by Country (2018-2029)
Figure 48. Europe C1 Esterase Inhibitor Sales Share by Country (2018-2029)
Figure 49. Germany C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 50. France C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 51. UK C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 52. Italy C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 53. Russia C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 54. China C1 Esterase Inhibitor Sales Market Share by Type (2018-2029)
Figure 55. China C1 Esterase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 56. China C1 Esterase Inhibitor Sales Market Share by Application (2018-2029)
Figure 57. China C1 Esterase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 58. Asia C1 Esterase Inhibitor Sales Market Share by Type (2018-2029)
Figure 59. Asia C1 Esterase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 60. Asia C1 Esterase Inhibitor Sales Market Share by Application (2018-2029)
Figure 61. Asia C1 Esterase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 62. Asia C1 Esterase Inhibitor Revenue Share by Region (2018-2029)
Figure 63. Asia C1 Esterase Inhibitor Sales Share by Region (2018-2029)
Figure 64. Japan C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 68. India C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales Share by Country (2018-2029)
Figure 75. Brazil C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 78. Israel C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries C1 Esterase Inhibitor Revenue (2018-2029) & (US$ Million)
Figure 80. C1 Esterase Inhibitor Value Chain
Figure 81. C1 Esterase Inhibitor Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries